Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Roblox
RBLX
|
+$2.08B |
| 2 |
KLA
KLAC
|
+$1.61B |
| 3 |
Northrop Grumman
NOC
|
+$1.53B |
| 4 |
Accenture
ACN
|
+$1.53B |
| 5 |
T-Mobile US
TMUS
|
+$1.29B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.71B |
| 2 |
GE Vernova
GEV
|
+$1.93B |
| 3 |
Darden Restaurants
DRI
|
+$1.73B |
| 4 |
Applied Materials
AMAT
|
+$1.45B |
| 5 |
AbbVie
ABBV
|
+$1.28B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28% |
| 2 | Industrials | 13.19% |
| 3 | Financials | 13% |
| 4 | Communication Services | 10.51% |
| 5 | Consumer Discretionary | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Legend Biotech
LEGN
$4.02B
| $38.4M | 0.01% |
1,082,473
-594,787
| -35% | -$19.3M |
|
352
Loar Holdings
LOAR
$6.76B
| $38.1M | 0.01% |
442,028
-59,356
| -12% | -$5.14M |
|
353
NewAmsterdam Pharma
NAMS
$3.32B
| $37.4M | 0.01% |
2,062,535
| – | – |
|
|
CGIB
354
Capital Group International Bond ETF USD-Hedged
CGIB
$318M
| $37.2M | 0.01% |
1,475,300
-199,992
| -12% | -$5.13M |
|
|
CMA
355
DELISTED
Comerica
CMA
| $36.5M | 0.01% |
+611,973
| New | +$34.1M |
|
356
BHP
BHP
$225B
| $36.3M | 0.01% |
747,052
+2,032
| +0.3% | +$97.7K |
|
|
AHL
357
DELISTED
Aspen Insurance
AHL
| $36.2M | 0.01% |
+1,150,000
| New | +$38.3M |
|
358
Spyre Therapeutics
SYRE
$9.03B
| $35.8M | 0.01% |
2,392,541
| – | – |
|
359
Radian Group
RDN
$4.9B
| $34.6M | 0.01% |
961,287
| – | – |
|
360
Affirm
AFRM
$25.4B
| $33.7M | 0.01% |
487,273
-808,775
| -62% | -$41.9M |
|
361
Structure Therapeutics
GPCR
$3.8B
| $33.6M | 0.01% |
1,618,876
-150
| -0% | -$3.3K |
|
362
CMS Energy
CMS
$22.1B
| $33.2M | 0.01% |
479,557
-68,609
| -13% | -$4.89M |
|
363
FTAI Infrastructure
FIP
$545M
| $33M | 0.01% |
5,345,350
| – | – |
|
364
Federal Signal
FSS
$7.72B
| $31.8M | 0.01% |
299,099
+71,147
| +31% | +$6.34M |
|
365
MSCI
MSCI
$41B
| $31.5M | 0.01% |
54,569
-391,464
| -88% | -$217M |
|
366
First Merchants
FRME
$2.73B
| $31.4M | 0.01% |
818,755
| – | – |
|
367
OneSpaWorld
OSW
$2.69B
| $31.2M | 0.01% |
1,528,664
-1,111,672
| -42% | -$20.4M |
|
368
Canadian Natural Resources
CNQ
$97B
| $30.7M | 0.01% |
977,643
+3,513
| +0.4% | +$106K |
|
369
Warrior Met Coal
HCC
$5.05B
| $30.7M | 0.01% |
+670,428
| New | +$31.1M |
|
370
FTI Consulting
FCN
$4.19B
| $30.7M | 0.01% |
190,072
| – | – |
|
371
Jack Henry & Associates
JKHY
$10.8B
| $30M | 0.01% |
167,224
+436
| +0.3% | +$77.4K |
|
372
Generac Holdings
GNRC
$13.2B
| $29.8M | 0.01% |
207,989
| – | – |
|
|
RAPP
373
Rapport Therapeutics
RAPP
$2.29B
| $29.6M | 0.01% |
2,602,529
| – | – |
|
374
Worthington Enterprises
WOR
$2.8B
| $29.1M | 0.01% |
457,502
| – | – |
|
375
Keurig Dr Pepper
KDP
$41.9B
| $28.2M | ﹤0.01% |
851,548
-71,448
| -8% | -$2.42M |
|
Similar funds
Capital International Investors's Q2 2025 Portfolio in Review
As of Q2 2025, Capital International Investors held 474 positions worth $581B, up 14% from $509B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Capital International Investors's Q2 2025 filing shows 33 new, 203 increased, 170 reduced and 31 closed positions. Its largest new stake was Royalty Pharma: 21,880,620 shares worth $788M. The largest sale was Broadcom, an estimated $2.71B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Industrials and Financials.
- Capital International Investors's largest Q2 2025 buy was Royalty Pharma: 21,880,620 shares worth $788M.
- Capital International Investors added most to Roblox in Q2 2025, an estimated $2.08B increase.
- Capital International Investors's biggest Q2 2025 reduction was Broadcom, cutting an estimated $2.71B.
- Capital International Investors fully exited Citigroup in Q2 2025, selling an estimated $604M.
- Capital International Investors's ten largest holdings make up 33% of its $581B portfolio in Q2 2025.
- Capital International Investors opened 33 new positions and closed 31 in Q2 2025.
- Capital International Investors's portfolio value rose 14% quarter-over-quarter to $581B.
Based on Capital International Investors's 13F filing for Q2 2025, filed 13 Aug 2025.